The mechanism
GLP-1 is a hormone your gut releases after you eat. Among other things it signals fullness to the brain, slows how quickly the stomach empties, and influences insulin release. GLP-1 receptor agonists are drugs that mimic it, at a much longer duration of action than the natural hormone.
The practical experience people describe is that food stops occupying their attention. Not willpower applied harder — the signal that drives eating is simply quieter. That is why the effect sizes are larger than anything achieved by over-the-counter products.
What the evidence supports
Several large randomised controlled trials, published in major peer-reviewed journals, have found substantial average weight loss over roughly a year compared with placebo, in participants who also received lifestyle support.
Two details matter. Those are averages, with wide individual variation — some participants lost a great deal and some lost very little. And the trials included structured diet and activity support alongside the drug, so the results describe the combination rather than the medication alone.
Side effects are common
Gastrointestinal effects — nausea, vomiting, diarrhoea, constipation — are the most frequently reported, and are a significant reason people discontinue. They are usually worst when the dose increases, which is why titration is slow and deliberate.
Rarer but serious risks appear in the labelling, including pancreatitis and gallbladder problems, and there is a contraindication relating to certain thyroid tumour histories. This is not a comprehensive list and it is not a substitute for reading the label with a clinician.
Compounded is not the same as approved
A large part of the low-cost telehealth market prescribes compounded versions of these medications. Compounding pharmacies operate legally under a different regulatory pathway, but a compounded product has not been through the FDA approval process and is not required to demonstrate equivalence to the approved drug.
The FDA has issued warnings relating to dosing errors with compounded GLP-1 products. If a service is dramatically cheaper than the rest of the market, this is usually why, and you should know that before you decide rather than after.
The question about stopping
Weight regain after discontinuation is well documented. The mechanism is not mysterious — the appetite signal returns when the drug that was suppressing it leaves.
This reframes the decision. For many people these medications are better understood as an ongoing treatment for a chronic condition than as a course you complete. Any programme that will not discuss this with you before you start is selling you a subscription and calling it care.
Muscle loss is a real consideration
Rapid weight loss from any cause includes lean tissue, not only fat. In the context of these medications, where intake can fall sharply, adequate protein and resistance training matter more than usual for preserving muscle.
Very few telehealth programmes include any support for this. It is one of the things we look for when scoring them.